-
Published18/06/2025
-
Deadline18/07/2025
-
Today18/07/2025
-
Opening of tenders18/07/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Successive supply of medicinal products used in the medicinal programme: ‘Treatment of patients with retinal diseases (ICD-10: H35.3, H36.0)’ for SP ZOZ MSWiA in Kraków Text automatically translated in your browsing language Automatically translated
The subject of the contract is the successive supply of medicinal products used in the drug program: ‘Treatment of patients with retinal diseases (ICD-10: H35.3, H36.0)’. The order is divided into 5 lots within 5 packages. A detailed description of the subject-matter of the contract is given in Annex 2 to these specifications. This description should be read together with any changes to the content of the specification, e.g. as a result of the answers given to the Contractors' inquiries. The quantities given are an estimate of the need for a period of 24 months and are used to calculate the price of the tender (i.e. to determine the maximum remuneration of the Contractor). The Ordering Party reserves the right to resign from the purchase of part of the assortment resulting from the lack of demand. Text automatically translated in your browsing language Automatically translated
https://platformazakupowa.pl/transakcja/1127277
https://platformazakupowa.pl/transakcja/1127277
33600000 - Pharmaceutical products
33690000 - Various medicinal products CVP code deduced from the text of the procedure AI-generated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.